Elsevier

Experimental Cell Research

Volume 316, Issue 12, 15 July 2010, Pages 1914-1924
Experimental Cell Research

Research Article
Eps8 is recruited to lysosomes and subjected to chaperone-mediated autophagy in cancer cells

https://doi.org/10.1016/j.yexcr.2010.02.020Get rights and content

Abstract

Eps8 controls actin dynamics directly through its barbed end capping and actin-bundling activity, and indirectly by regulating Rac-activation when engaged into a trimeric complex with Eps8-Abi1-Sos1. Recently, Eps8 has been associated with promotion of various solid malignancies, but neither its mechanisms of action nor its regulation in cancer cells have been elucidated. Here, we report a novel association of Eps8 with the late endosomal/lysosomal compartment, which is independent from actin polymerization and specifically occurs in cancer cells. Endogenous Eps8 localized to large vesicular lysosomal structures in metastatic pancreatic cancer cell lines, such as AsPC-1 and Capan-1 that display high Eps8 levels. Additionally, ectopic expression of Eps8 increased the size of lysosomes. Structure–function analysis revealed that the region encompassing the amino acids 184–535 of Eps8 was sufficient to mediate lysosomal recruitment. Notably, this fragment harbors two KFERQ-like motifs required for chaperone-mediated autophagy (CMA). Furthermore, Eps8 co-immunoprecipitated with Hsc70 and LAMP-2, which are key elements for the CMA degradative pathway. Consistently, in vitro, a significant fraction of Eps8 bound to (11.9 ± 5.1%) and was incorporated into (5.3 ± 6.5%) lysosomes. Additionally, Eps8 binding to lysosomes was competed by other known CMA-substrates. Fluorescence recovery after photobleaching revealed that Eps8 recruitment to the lysosomal membrane was highly dynamic. Collectively, these results indicate that Eps8 in certain human cancer cells specifically localizes to lysosomes, and is directed to CMA. These results open a new field for the investigation of how Eps8 is regulated and contributes to tumor promotion in human cancers.

Introduction

The epidermal growth factor receptor pathway substrate 8 (Eps8) is a 97 kDa protein that was originally identified as a substrate for the kinase activity of the epidermal growth factor receptor (EGFR). Early results demonstrated that Eps8 increases epidermal growth factor (EGF) responsiveness, thus contributed to malignant transformation in tumor cells [1], [2]. There is now growing evidence that Eps8 plays an important role in promotion of various solid malignancies, including colon, squamous cell, thyroid and cervical cancer [3], [4], [5], [6], [7]. We recently reported that Eps8 expression is enhanced in metastatic pancreatic cancer cells when compared to cells from the primary tumor [8]. Moreover, high Eps8 expression in metastatic cells was associated with increased cell motility and accumulation of Eps8 at actin dynamic sites, e.g. the leading edge of the cells.

The Eps8 molecule controls actin remodeling through multiple interactions. The C-terminal “effector region” directly binds F-actin and caps actin barbed ends [9]. In addition, Eps8 participates in the activation of the small GTPase Rac in a tri-protein complex with Abi1 and Sos1, and synergizes with IRSp53 to bundle actin filaments [10]. A number of recent evidences indicate that actin dynamics and endocytic machineries are intimately related. This notion appears to apply also in the case of Eps8. Rac-signaling through Eps8 can be hampered by binding of RN-tre, a GTPase activating protein (GAP) for Rab5, to the src homology-3 (SH3) domain of Eps8, leading to disruption of the Eps8-Abi1-Sos-1 complex and to the de-activation of Rab5, which in turns regulates the internalization of EGFR [11]. Intriguingly, Rab5-dependent endocytosis and early endosome trafficking have recently been shown to be required for Rac-mediated, spatially restricted actin remodeling at the cell periphery [12].

Within this context, Eps8 has all the features to posit that it might be an important regulatory element mediating the cross talk between membrane and actin dynamics, which ultimately is required to generate propulsive force at the leading cell edge. However, whether Eps8 directly participates in membrane internalization and/or endomembrane trafficking remains unclear. Since there is little known about the degradation of Eps8 [13], it might be possible that the regulatory function of Eps8 is controlled through its expression levels.

Chaperone-mediated autophagy (CMA) is a cellular process for the selective degradation of cytosolic proteins [14]. Unlike other forms of autophagy, CMA mediates the direct translocation of individual proteins across the lysosome membrane for their degradation in the lysosome [15], [16]. CMA activity decreases with age and has shown to be altered in different human pathologies [17], [18]. Malfunctioning autophagy has been closely linked to oncogenic signaling [19].

Here, we investigate a novel association of Eps8 to the lysosomal compartment in human cancer cells and describe its degradation through CMA.

Section snippets

Expression vectors, antibodies, reagents and siRNA

Vectors encoding for GFP fusion proteins were engineered in the pEGFP C1 plasmid (Clontech Laboratories, Inc.) by cloning the appropriate fragments, obtained by recombinant PCR, in frame with the GFP moiety as described recently [20]. All constructs were sequence verified. Details are available upon request. Cell transfection was performed with Lipofectamine 2000 (Invitrogen, Eugene, OR) according to the manufacturer's instructions.

The antibodies used were: mouse monoclonal anti-Eps8

Results

We recently described that Eps8 localizes to dynamic actin structures, i.e. to the tips of F-actin filaments in filopodia, and to the leading edge of pancreatic cancer cells, and that various pancreatic cancer cell lines expressed different mRNA and protein levels of Eps8 according to the following order: PANC-1<Capan1<AsPC-1 [8].

In addition to the spot-like, F-actin-associated pattern (such as in PANC-1 cells, Figs. 1A, B), endogenous Eps8 strikingly localized also to large vesicular

Discussion

Here, we describe a novel and unexpected association of endogenous Eps8 with the lysosomal compartment in human cancer cell lines. Eps8 has been associated with dynamic actin sites and the early endocytic compartment [1], [9], [10], [11], [20], [26], [27]. These interactions are mediated by either the SH3-domain (Abi1 and RN-tre binding), or by the C-terminal “effector region” (Sos1 and F-actin binding), respectively. The protein region that was responsible for the lysosomal localization of

Conflict of interest

The authors state no conflict of interest in this study.

Acknowledgments

We would like to thank Sonja Bauer for her excellent technical assistance. This work was partly supported by the NIH Grant AG021904 (to AMC).

References (31)

  • B. Matoskova et al.

    Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation

    Mol. Cell Biol.

    (1995)
  • Y.J. Chen et al.

    Eps8 decreases chemosensitivity and affects survival of cervical cancer patients

    Mol. Cancer Ther.

    (2008)
  • O.L. Griffith et al.

    Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers

    J. Clin. Oncol.

    (2006)
  • H. Wang et al.

    Role for EPS8 in squamous carcinogenesis

    Carcinogenesis

    (2009)
  • J. Yao et al.

    Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression

    Cancer Res.

    (2006)
  • Cited by (39)

    • Nitric oxide mediated redox regulation of protein homeostasis

      2019, Cellular Signalling
      Citation Excerpt :

      The SNOing of HSPA8 likely interferes with the binding and transfer process [50]. A number of typical CMA-targets [28,29,135–137] including aldolase A, annexin A2 and -6, transcription intermediary factor 1-beta (TRIM28), elongation factor 2, Rho-related GTP-binding protein (RND3), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and DNA-dependent protein kinase (PRKDC) all accumulated in NOS1 positive SY-5YSH cells upon exposure to starvation [50]. On the cytosolic site, this lysosomal import via LAMP2a requires that HSPA8 associates with its cochaperones HSP90, BAG1, HSP40, ST13, and STIP1/HOP, out of which HSP90, ST13 and BAG1 are further SNO targets [50].

    • Nitric oxide contributes to protein homeostasis by S-nitrosylations of the chaperone HSPA8 and the ubiquitin ligase UBE2D

      2019, Redox Biology
      Citation Excerpt :

      Transcription of these candidates rather decreased on rapamycin stimulation or remained constant and did not differ between cell lines as far tested (Fig. 2D). Further CMA substrates were increased in nNOS+ cells on serum-free starvation including RND3 [68] and EPS8 [69] (Fig. 7C). Gene Ontology Overrepresentation analysis (ORA) revealed that differentially expressed proteins were involved in four major "biological processes" that can be captured with “protein folding”, “glycolysis”, “response to stress” and "protein complex assembly” (DIB2_Table 2).

    • Chaperone-mediated autophagy and kidney disease

      2018, Autophagy and Cardiometabolic Diseases: From Molecular Mechanisms to Translational Medicine
    • Actin binding proteins, spermatid transport and spermiation

      2014, Seminars in Cell and Developmental Biology
      Citation Excerpt :

      Eps8 is also a product of oncogene and an emerging target of anticancer therapy [79]. Eps8 is an important regulator of F-actin organization, which induces actin barbed end capping, actin bundling, and modulation of Rac GTPase-mediated actin remodeling [80,81]. Structurally, Eps8 contains several functional domains: a phosphotyrosine binding (PTB) domain, an EGFR binding region, two proline-rich (PR) sequences, a Src homology 3 (SH3) domain and a sterile α motif/pointed domain (SAM–PNT domain) overlapped by a C-terminal ‘effector’ region (Fig. 2).

    View all citing articles on Scopus
    View full text